807 related articles for article (PubMed ID: 19544486)
21. Class II major histocompatibility complex-restricted T cell function in CD4-deficient mice.
Rahemtulla A; Kündig TM; Narendran A; Bachmann MF; Julius M; Paige CJ; Ohashi PS; Zinkernagel RM; Mak TW
Eur J Immunol; 1994 Sep; 24(9):2213-8. PubMed ID: 7916297
[TBL] [Abstract][Full Text] [Related]
22. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.
Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
J Immunol; 2009 Nov; 183(10):6561-8. PubMed ID: 19846882
[TBL] [Abstract][Full Text] [Related]
23. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
24. Characterization of CD25-positive T cells during syngeneic pregnancy: production of stimulatory class II MHC molecules.
Kyvelidou C; Chatzi K; Semitekolou M; Papathanassiou X; Vassiliadis S; Athanassakis I
Scand J Immunol; 2009 Dec; 70(6):584-95. PubMed ID: 19906201
[TBL] [Abstract][Full Text] [Related]
25. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
[TBL] [Abstract][Full Text] [Related]
26. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
[TBL] [Abstract][Full Text] [Related]
27. CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hosts.
den Boer AT; van Mierlo GJ; Fransen MF; Melief CJ; Offringa R; Toes RE
Cancer Res; 2005 Aug; 65(15):6984-9. PubMed ID: 16061684
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.
Zimmermann M; Flechsig C; La Monica N; Tripodi M; Adler G; Dikopoulos N
J Hepatol; 2008 Jan; 48(1):51-60. PubMed ID: 17998148
[TBL] [Abstract][Full Text] [Related]
29. Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery.
Rodríguez T; Pérez O; Ménager N; Ugrinovic S; Bracho G; Mastroeni P
Vaccine; 2005 Jan; 23(10):1312-21. PubMed ID: 15652674
[TBL] [Abstract][Full Text] [Related]
30. Generation of CD4(+) and CD8(+) T lymphocyte responses by dendritic cells armed with PSA/anti-PSA (antigen/antibody) complexes.
Berlyn KA; Schultes B; Leveugle B; Noujaim AA; Alexander RB; Mann DL
Clin Immunol; 2001 Dec; 101(3):276-83. PubMed ID: 11726219
[TBL] [Abstract][Full Text] [Related]
31. IL-17 production elicited by allo-major histocompatibility complex class II recognition depends on CD25posCD4pos T cells.
Benghiat FS; Craciun L; De Wilde V; Dernies T; Kubjak C; Lhomme F; Goldman M; Le Moine A
Transplantation; 2008 Apr; 85(7):943-9. PubMed ID: 18408572
[TBL] [Abstract][Full Text] [Related]
32. Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene.
Bour H; Peyron E; Gaucherand M; Garrigue JL; Desvignes C; Kaiserlian D; Revillard JP; Nicolas JF
Eur J Immunol; 1995 Nov; 25(11):3006-10. PubMed ID: 7489735
[TBL] [Abstract][Full Text] [Related]
33. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity.
Smith CM; Wilson NS; Waithman J; Villadangos JA; Carbone FR; Heath WR; Belz GT
Nat Immunol; 2004 Nov; 5(11):1143-8. PubMed ID: 15475958
[TBL] [Abstract][Full Text] [Related]
34. Multiple survival signals are delivered by dendritic cells to naive CD4+ T cells.
Feuillet V; Lucas B; Di Santo JP; Bismuth G; Trautmann A
Eur J Immunol; 2005 Sep; 35(9):2563-72. PubMed ID: 16078277
[TBL] [Abstract][Full Text] [Related]
35. CD4(+) T cells stimulate memory CD8(+) T cell expansion via acquired pMHC I complexes and costimulatory molecules, and IL-2 secretion.
Shi M; Hao S; Chan T; Xiang J
J Leukoc Biol; 2006 Dec; 80(6):1354-63. PubMed ID: 16980510
[TBL] [Abstract][Full Text] [Related]
36. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts.
Malowany JI; McCormick S; Santosuosso M; Zhang X; Aoki N; Ngai P; Wang J; Leitch J; Bramson J; Wan Y; Xing Z
Mol Ther; 2006 Apr; 13(4):766-75. PubMed ID: 16343993
[TBL] [Abstract][Full Text] [Related]
37. DX5(+)CD4(+) T cells modulate cytokine production by CD4(+) T cells towards IL-10 via the production of IL-4.
Han WG; van der Voort EI; el Bannoudi H; Louis-Plence P; Huizinga TW; Toes RE
Eur J Immunol; 2010 Oct; 40(10):2731-40. PubMed ID: 20812238
[TBL] [Abstract][Full Text] [Related]
38. IL-4 deficiency does not impair the ability of dendritic cells to initiate CD4+ and CD8+ T cell responses in vivo.
Roberts JM; Yang J; Ronchese F
Int Immunol; 2004 Oct; 16(10):1451-8. PubMed ID: 15326095
[TBL] [Abstract][Full Text] [Related]
39. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
[TBL] [Abstract][Full Text] [Related]
40. Anti-tumor activity of dendritic cells transfected with mRNA for receptor for hyaluronan-mediated motility is mediated by CD4+ T cells.
Fukui M; Ueno K; Suehiro Y; Hamanaka Y; Imai K; Hinoda Y
Cancer Immunol Immunother; 2006 May; 55(5):538-46. PubMed ID: 16025267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
